SMTL ID : 6gqq.1

Crystal structure of human KDR (VEGFR2) kinase domain in complex with AZD3229-analogue (compound 35)

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 1.52 Å

Oligo State

monomer

Ligands

1 x F8B: ~{N}-[4-(6,7-dimethoxyquinazolin-4-yl)oxyphenyl]-2-(4-propan-2-yl-1,2,3-triazol-1-yl)ethanamide(Non-covalent)

F8B.1: 19 residues within 4Å: Chain A: L.35, V.43, A.61, K.63, E.80, L.84, I.87, V.94, V.111, E.112, F.113, C.114, K.115, G.117, L.180, I.189, C.190, D.191, F.192 12 PLIP interactions: 12 interactions with chain A Hydrophobic interactions: A:V.43, A:I.87, A:V.111, A:F.113, A:L.180, A:I.189, A:F.192, A:F.192 Hydrogen bonds: A:E.80, A:C.114, A:D.191 Water bridges: A:E.80

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Kettle, J.G. et al., Discovery of N-(4-{[5-Fluoro-7-(2-methoxyethoxy)quinazolin-4-yl]amino}phenyl)-2-[4-(propan-2-yl)-1 H-1,2,3-triazol-1-yl]acetamide (AZD3229), a Potent Pan-KIT Mutant Inhibitor for the Treatment of Gastrointestinal Stromal Tumors. J. Med. Chem. (2018)

Release Date

2018-09-19

Peptides

Vascular endothelial growth factor receptor 2: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Vascular endothelial growth factor receptor 2

Related Entries With Identical Sequence